Cartalax 20 MG

Cartalax is a cartilage-specific peptide bioregulator (Ala-Glu-Asp-Pro) studied for its potential to support joint integrity, cartilage regeneration, and connective-tissue resilience. It is explored for its role in modulating cellular repair processes in the musculoskeletal system and promoting long-term joint function.

BENEFITS

• Promotes cartilage regeneration and extracellular matrix synthesis.
• Supports joint flexibility and connective-tissue health.
• Explored for reducing inflammation and oxidative stress in cartilage cells.
• Research interest in age-related joint degeneration and injury recovery.
• May assist in maintaining mobility and structural resilience.

WHAT RESEARCHERS LOOK AT

• Peptide bioregulation of chondrocyte activity and matrix renewal.
• Gene expression modulation in cartilage repair pathways.
• Comparative studies with collagen-supportive bioregulators.
• Cartilage tissue recovery and cellular regeneration in degenerative models.

QUICK SPECS

• Form: Lyophilized peptide
• Net per vial: 20 mg
• Purity: ≥99% (HPLC)
• Identity: MS-verified (per COA)
• Storage: 2–8 °C, protect from light

IDENTITY BASICS

• Sequence: Ala-Glu-Asp-Pro
• Formula / M.W.: C14H21N3O8, ~359.33 g/mol
• CAS: 129564-87-8

SELECTED RESEARCH

• Peptide regulation of cartilage cells: https://pubmed.ncbi.nlm.nih.gov/24237062/
• Cartilage repair and chondrocyte gene studies: https://pubmed.ncbi.nlm.nih.gov/20470512/
• Peptide bioregulation in connective tissue: https://pubmed.ncbi.nlm.nih.gov/23924646/

DISCLAIMER

• This product is intended for laboratory research use only.

• Not for human or veterinary use.

• Not approved for diagnostic, therapeutic, or medical applications.

• Handle using appropriate laboratory safety procedures and personal protective equipment.